genes. This finding suggests that HFE expression directly affects the intracellular chelatable iron pool in the transgenic cell line. Furthermore, cells treated with the iron donors hemin or ferric ammonium citrate display response patterns that permit the identification of the iron loaded state in both cases, and to discriminate between the sources of iron loading. These findings also demonstrate the broad utility of gene expression profiling with the "IronChip" to study iron metabolism and related human diseases.
Introduction
Iron is a nutrient that plays an essential role in biological functions. It mediates oxygen transport by hemoglobin and constitutes an essential component of the respiratory chain by conferring redox activity on the cytochromes and other enzymes. However, iron can also damage tissues by catalyzing the conversion of hydrogen peroxide to free-radical ions that attack cellular membranes, proteins and DNA [1, 2] . It is hence not surprising that both iron deficiency and iron overload cause pathologic changes. Disorders of iron homeostasis are among the most common inherited diseases of humans [3, 4] . To tightly control iron homeostasis, a complex network of iron transporters, storage molecules and regulators has evolved. To interface iron metabolism with other metabolic activities of cells, regulators of iron metabolism also respond to non-iron signals such as NO and oxidative stress [5, 6] .
Iron homeostasis is regulated at the systemic and at the cellular level. The expression of central proteins involved in iron uptake and transport, iron storage and iron utilization is controlled by the IRE/IRP regulatory system. IREs (iron-responsive elements) are RNA elements that function as binding sites for IRP (iron regulatory protein) -1 and IRP-2.
IRP-1 or IRP-2 bound to a single IRE in the 5' untranslated region (UTR) of an mRNA 4 (NO) affect IRP activity [22] [23] [24] [25] [26] [27] [28] [29] , linking the regulation of iron metabolism to the oxidative stress and nitric oxide pathways.
In addition to IRP-mediated post-transcriptional regulation, transcriptional control mechanisms regulate important aspects of cellular iron homeostasis. For example, the transcription of the transferrin receptor gene is activated by hypoxia inducible factor 1 (HIF-1 ) [30] [31] [32] and is downregulated by TNF-and IL-1 in alveolar epithelial cells [33] . L-ferritin mRNA transcription is induced by prostaglandin A1 [34] , and H-ferritin transcription is augmented by c-jun in cultured HeLa cells [35] . Both the H-ferritin and IRP-2 genes are targeted by c-myc, and the regulation of these genes is thought to contribute to c-myc-dependent cell proliferation and transformation [36] .
The positional cloning of the gene affected in hereditary hemochromatosis (HC) [37] resulted in the identification of a novel protein with a role in iron homeostasis, termed HFE. HC is characterized by systemic iron overload from increased duodenal iron absorption [38] . HFE is an MHC class-1 like protein [37] that forms a heterodimer with 2 microglobulin ( 2M). A missense mutation (C282Y) in the extracellular domain of HFE alters its conformation and abrogates 2M binding, which results in a loss of HFE protein presentation on the cell surface [39, 40] . Other polymorphisms have been found in the HFE gene but their clinical significance is less clear [37, 41, 42] . A biochemical link between HFE and cellular iron metabolism was established with the finding that HFE can engage in high affinity interactions with the transferrin receptor [43, 44] . This interaction interferes with the binding of transferrin to the transferrin receptor, and thus reduces cellular iron uptake [43, 45, 46] . We previously developed a stable HeLa cell line For personal use only. on November 16, 2017. by guest www.bloodjournal.org From in which HFE is expressed under the control of a tetracycline-responsive promoter [47] .
We demonstrated that the induction of HFE expression results in decreased iron uptake from diferric transferrin. Moreover, HFE expression activates IRP activity and thus causes reduced synthesis of the iron storage protein ferritin and an increase in transferrin receptor levels [47] . Recently, HFE was overexpressed in Chinese hamster ovary cells [48] . Similar to the observations in HeLa cells [47, 49] , HFE overexpression caused a decrease in transferrin-mediated iron uptake. However, the combined expression of both HFE and 2M increased TfR1-dependent iron uptake and cellular iron levels. It was reported that the HFE-2M complex enhances the rate of TfR1 recycling and results in an increased steady-state level of TfR1 at the plasma membrane of these stably transfected cells [48] . Thus, the availability of 2M may affect HFE function and iron homeostasis.
Gene expression profiling using DNA microarrays has allowed to broaden gene expres sion analyses from studying single genes to investigating complex regulatory networks [50] [51] [52] . Here, we report the development of the "IronChip", a cDNA-based microarray that represents human genes directly involved in iron metabolism or in interlinked pathways such as oxidative stress, NO metabolism or copper metabolism. We analyzed the genetic response patterns of HeLa cells to iron perturbation as well as exposure to oxidative stress and the NO+ donor sodiumnitroprusside (SNP). We demonstrate that the resulting regulatory patterns reflect degrees of relationship between the different signals. Remarkably, the gene responses elicited by HFE induction and by pharmacological iron chelation exhibit the highest degree of relatedness, both for IRPand non-IRP target genes. This finding suggests that HFE expression directly targets the regulatory iron pool(s) of the transfected cells. 
Materials and Methods

Selection of cDNA clones
The genes that are immobilized on the "IronChip" were selected based on (i) literature searches, (ii) microarray experiments performed on filters that contain approximately 20000 human non-redundant ESTs comparing hemin and desferrioxamine treated CaCo2 cells and (iii) gene lists from published microarray studies that address metabolic pathways of interest.
113 human 'expressed sequence tag' (EST) clones, that were sequence verified from both ends were chosen for the "IronChip" (version 2.0) (http://www.emblheidelberg.de/ExternalInfo/hentze/suppinfo.html.) The ESTs were selected to contain the 3'end of a cDNA (i.e. the polyadenylation signal) and to extend for at least 300bp towards the 5' end. The clone finder software, developed by the HUSAR Biocomputing Service Group at the German Cancer Research Center (http://genome.dkfz-heidelberg.de) facilitated the selection. The clones were purchased from the German Resource Center (RZPD).
Preparation of the "IronChip" microarray platform
The preparation of the "IronChip" microarray platform, which includes amplification, spotting and attachment of the cDNAs is described elsewhere [53] . The same reference outlines the use of positive and negative hybridization controls integrated into the analysis to determine the cut-off signals for noise as well as the cut-off ratio for differential expression on the "IronChip". At least two independent cell culture experiments were performed for each experimental condition tested. Cy3 fluorescent dyes were incorporated into the cDNA synthesized from the control sample and Cy5 fluorescent dyes into cDNA synthesized from the experimental sample and vice versa. This 'dye switch' helps to eliminate technical artifacts that derive from the biophysical properties of the two different dyes. Genes were only scored as differentially expressed if they displayed a consistent regulatory pattern in such dye switch experiments.
Microarray analysis
The microarrays were immersed at 42°C in 6xSSC/0,5%SDS/1%BSA for 40 min and subsequently washed extensively with ddH2O at room temperature. Prior to hybridization, the spotted PCR products were denatured by immersing the slides at 95°C in ddH2O for 2 min. Excess of liquid was removed from the slides by centrifuging them briefly at 715xg in a microtiter plate centrifuge (Z320, Hermle, Wehingen, Germany).
Prior to hybridization, the purified Cy3 and Cy5 labeled cDNAs were mixed, 5 µg poly(dA) and 1 µg human Cot1 DNA (both Gibco Invitrogen Corp., Carlsbad, Ca, USA)
were added and subsequently evaporated in a vacuum Concentrator 5301 (Eppendorf,
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Hamburg, Germany) at 60°C. The resulting pellet was dissolved in 12 µl hybridization buffer (50% formamide / 6xSSC / 0,5%SDS / 5x Denhardt) and denatured by incubating at 95°C for 2 min. The probe was then transferred onto the array under a 24x24 mm coverslip and incubated in a humid chamber (GeneMachines, San Carlos, CA, USA) containing 2xSSC drops for providing humidity. Hybridization was performed for 12h to 16h in a 42°C waterbath (GFL, Burgwedel, Germany).
After hybridization the microarrays were washed in 0,1xSSC / 0,1%SDS for 10 min and twice with 0,1xSSC for 5 min (on an orbital shaker), followed by a brief immersion of the slides in ddH2O. Finally, the washed slides were dried by centrifuging them briefly at 715xg in a microtiter plate centrifuge (Z320, Hermle, Wehingen, Germany). All washing steps were performed at room temperature.
Scanning and data analysis
All microarrays were scanned on a GenePix 4000B Microarray Scanner (Axon 
Cell culture, RNA extraction and Northern analysis:
The maintenance of cultured HeLa cells and the treatments with 100µM hemin, 100µM ferric ammonium citrate, 100µM desferrioxamine, 100µM H 2 O 2 and 100µM SNP were performed as described previously [27] . All treatments were performed for 8 hours. The establishment and maintenance of the HFE over expressing cell line as well as the experimental conditions of HFE over expression are described in [47] The preparation of cytoplasmic extracts from HeLa cells and sucrose gradient centrifugation was described previously [55] . Total RNA was extracted from the sucrose gradient fractions as described in [56] .
Results
Validation of the human "IronChip"
We first established a cDNA microarray platform that represents a selection of human genes which are directly involved in iron metabolism or which play a role in interlinked pathways such as copper metabolism, NO metabolism, the redox pathway, stress responses, selenium metabolism or cell growth ("IronChip"). In addition, we included control genes that are not expected to be affected by the experimental conditions, as well as genes that are not represented in the human genome and hence serve as negative In addition to those genes that are directly involved in iron metabolism, we found some additional genes to be regulated. In iron replete cells, three members of the heat shock protein (hsp) family [hsp70D (M11717), hsp105 ( 003334) and the mitochondrial (m) hsp70 (L11066)] and three genes mediating growth effects [c-myc (V00568) and growth arrest specific (gas)-1 (L13698) and 3 (L03203)] show increased mRNA levels.
In iron deficient cells, we observe a robust increase in the amount of mRNAs encoding metallothionine (mt)-2 (X97260), lysyl oxidase (lox; M94054), and a small but consistent increase in the mRNA level of hypoxia inducible factor HIF-1 (NM_001530). 
Gene expression profiles derived from hemin and ferric ammonium citrate (FAC) treated HeLa cells.
We next assessed HeLa cells that were treated with two different sources of iron, hemin (ferric protoporphyrin IX) or ferric ammonium citrate (FAC), to address two questions:
first, whether the iron loaded state resulting from both treatments elicited a common pattern in the respective expression profiles; second, whether these two similar treatments could be discriminated by diagnostic features of the respective gene response patterns.
Subconfluent HeLa cells were treated either with 100µM hemin or 100µM FAC for 8
hours. Untreated HeLa cells were used as a control for both. As can be seen in figure treatment induced increased HO-1 and TfR-1 mRNA levels ( fig.3a) . The induction of HO-1 by H 2 O 2 has been reported previously [65] . By contrast, we neither observe the regulation of the IRE-containing DMT1/ DCT1/Nramp2 mRNA, nor any regulation of In addition to iron perturbation and oxidative stress, also nitric oxide affects IRP activity and the regulation of IRE-containing mRNAs [22, 24, 25, 27, 28] . Thus, we also tested the effect of sodium nitroprusside (SNP), which releases nitrosonium ions (NO+), on the regulation of the genes immobilized on the "IronChip". NO+ has been suggested to cause the S-nitrosylation of critical thiol groups, to prevent the binding of IRP-2 to IREs, and to result in TfR-1 mRNA degradation [66] .
HeLa cells were treated with 100µM SNP for 8 hours; total RNA was extracted and analyzed on the "IronChip" in comparison to an untreated control sample. As expected, SNP treatment reduces TfR mRNA levels (fig 3b) . In addition, the mRNA levels of the 
HFE expression and iron deficiency yield highly similar gene expression profiles
Previous work showed that induced HFE expression in mammalian cells resulted in decreased iron uptake from diferric transferrin, IRP activation, and the regulation of IRP target mRNAs [43, 46, 47, [67] [68] [69] [70] . These findings suggested that HFE expression in transfected cells affects the regulatory "labile iron pool" in a way that is similar to desferrioxamine-induced iron starvation. To record the responses of transfected HeLa cells to induced HFE expression more globally and to compare these with the response of desferrioxamine-treated cells, additional microarray analyses were performed.
HeLa cells were stably transfected with the human HFE cDNA under the control of a doxycyclin-responsive promoter [47] . The absence of doxycyclin induces HFE expression [47] , whereas the transgene is not transcribed following the addition of doxycyclin to the culture medium. Total RNA extracted from doxycyclin-treated and untreated HeLa cells bearing the HFE transgene was used for fluorescent cDNA synthesis and subsequent analysis on the "IronChip". As expected, the HFE mRNA is strongly induced in the absence of doxycyclin ( fig.4a ). When HFE expression is induced, TfR-1, c-jun, lysyl oxidase and Mt-2 mRNAs are increased, whereas the mRNA levels of HO-1, Hsp70D, Hsp105a, mHsp70, L-Fer and Gas-3 decrease. These data were confirmed by northern analysis (fig.4b ). Doxycyclin treatment of non-transfected HeLa cells did not affect the regulation of "IronChip" genes (data not shown). When HeLa cells were treated with 100µM desferrioxamine, TfR-1, c-jun and lysyl oxidase mRNA levels increased.
Decreased mRNA levels were found for HO-1, Hsp70D, Hsp105a, mHsp70, L-Fer, Gas 1 and Gas 3 and c-myc (Fig.4a) .
These data sets reveal striking similarities between the gene responses elicited by HFE expression and desferrioxamine treatment, respectively. This conclusion applies both to IRP-target genes and non-IRP target genes ( fig.4c ). Both gene response patterns significantly differ from those elicited by e.g. SNP and H 2 O 2 treatment (fig 3) . Thus, we conclude that HFE expression in transfected HeLa cells triggers cellular iron deficiency.
Monitoring translational responses to iron perturbations by microarray analyses
Traditionally, microarray analyses are employed to monitor changes in steady state mRNA levels. Because gene regulation in response to iron perturbations also prominently involves translational control in the absence of concomitant changes in mRNA levels, we wanted to adapt our experimental approach to reveal regulation at the translational level.
Cytoplasmic extracts were prepared from HeLa cells that were treated with either hemin or desferrioxamine, and subjected to linear sucrose gradient centrifugation (see Materials and Methods). Six fractions were prepared from each sample, total RNA was extracted and initially analyzed by Northern blotting. As shown in fig.5a , L-ferritin mRNA is enriched in the polysomal fractions at the bottom of the sucrose gradient in hemin-treated cells, as previously observed [56] . In iron deficient cells, L-ferritin mRNA is enriched in the fractions that contain monosomes (80S) and mRNPs, consistent with previous findings that IRP inhibits the translation of ferritin mRNAs by interfering with the first steps of the translation initiation process [71] . As a control, actin mRNA remains localized in the polysomal fractions in both hemin-and desferrioxamine-treated cells.. 
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For microarray analyses, we pooled the total RNA derived from the polysomal fractions 1-3 and the total RNA derived from the monosomal/mRNP fractions 4-5, respectively.
For each condition (hemin and desferrioxamine treatment), the polysomal and monosomal/mRNP fractions were labeled with different fluorescent dyes and hybridized to the "IronChip". Similar to the Northern blots, the data ( fig. 5b) 
Discussion
We have studied the genetic responses of a human cell line to changes in iron metabolism employing a newly developed cDNA-based microarray platform ("IronChip"). Using this approach, novel insights into human iron metabolism were obtained (see below). In addition, the results show the utility of the "IronChip" as a versatile tool to investigate a broad range of questions regarding the physiology of human iron metabolism and diseases that result from its aberrations. 
New insights into human iron metabolism
Human HeLa cells have served as an intensively characterized model system for the investigation of iron metabolism. We therefore chose HeLa cells to explore the utility of a specialized DNA microarray that represents 113 different human genes and that was expected to reveal insights into regulatory responses of human cells to iron deficiency, iron overload, HFE expression and small signaling molecules. Table 1 (table 1) . However, Hsp70D mRNA levels responded to iron deficiency (and to HFE expression) and iron overload more strongly than TfR1 mRNA levels, which are often considered to be the For personal use only. on November 16, 2017. by guest www.bloodjournal.org From classic regulatory response to these challenges. It is also notable that Gas 3 and mHsp70 are consistently regulated by altered cellular iron supply. The latter result establishes mitochondrial Hsp70 (mHsp70) as a human iron-responsive gene and reveals that this regulation appears to be conserved between man and yeast: yeast mutants (ssc2-1) of mHsp70 show increased cellular iron uptake and the excess iron accumulates in the mitochondria [75] . It will be important to explore whether the induction of mHsp70 in iron-loaded cells fulfills a protective or a regulatory function in human cells.
Previous studies indicated that the heterologous or induced expression of the HFE protein negatively affects cellular iron uptake via the transferrin receptor [43, 46, 47, [67] [68] [69] [70] and hence triggers an iron deficiency response by the IRE/IRP regulatory network [47, 69] .
We find that desferrioxamine treatment and the induction of HFE expression, respectively, yield nearly identical responses of the 113 genes represented on the "IronChip". This allows the conclusion that HFE expression in this experimental system not only triggers an iron deficiency response by the IRE/IRP network. Rather, the iron deficiency state induced by HFE affects every regulatory system that is also reached by desferrioxamine [76] [77] [78] . Since the list of regulated genes includes non-IRP target genes such as the growth effect genes (e.g. c-jun, Gas3) and stress response genes (e.g. HO-1, Hsp70D,Hsp105 , mHSP70), we suspect that at least a part of these responses may be mediated transcriptionally. Regarding the putative function of HFE as an inducer of cellular iron deficiency, one needs to consider that we expressed HFE without induced co-expression of its heterodimerization partner 2 microglobulin. It has been reported that the co-expression of both yields opposite effects to the induction of HFE alone [48] .
From a more methodological perspective, the close resemblance of the desferrioxamine- The similarity between the genetic responses to iron overload by hemin and ferric ammonium citrate (FAC), respectively, was predicted and has been confirmed with the "IronChip" (fig. 2) . Most genes that respond to FAC also respond to hemin, and the latter response is usually slightly stronger. As an exception to this, the HO-1 mRNA response to hemin is far stronger than to FAC. Considering the biological role of HO-1 in heme breakdown, a more profound induction of HO-1 mRNA by hemin is not surprising. We suggest that the magnitude of the HO-1 response in relation to the responses by mHsp70, L-fer, Gas3, TfR1 and Mt-2 is "diagnostic" for hemin-induced versus FAC-induced iron overload. More generally, this analysis provides an example for the possibility to discriminate between two related stimuli by "IronChip analysis".
The "IronChip" provides a versatile tool for the analysis of iron metabolism
As illustrated above, the human "IronChip" was validated as a reliable assay system to identify the responses of more than a hundred genes involved in iron metabolism and interlinked biological pathways. We also show that in combination with sucrose gradient analysis, the "IronChip" successfully identifies genetic responses at the translational level ( fig. 5 ). This is particularly pertinent for the study of mammalian iron metabolism [13] .
Compared to far more comprehensive cDNA or oligonucleotide-based microarrays, the "IronChip" offers only limited chances to identify "new genes" that are regulated by particular stimuli. For this reason, we believe that more comprehensive microarrays can offer helpful entry points for microarray studies and help to identify genes to be included on the "IronChip", as was done during the original design and is being used for updated versions (see below). On the other hand, we believe that both gene verification and technical performance parameters of the "IronChip" compare favorably with those of larger arrays. All the genes represented on our arrays have been sequence verified from both ends. Due to the limited number of genes, each gene can be spotted multiple times and in different locations of the chip, and many genes are represented by up to three independent cDNA clones. This redundancy offers additional controls for gene specificity.
A major application of the "IronChip" lies in the identification of gene regulatory patterns that provide a characteristic "fingerprint" of a particular treatment or genetic alteration. For this application, the technical quality of the data is critical, particularly the ability to score limited quantitative differences reliably and reproducibly. The recognition of similarities or differences in the genetic responses to different stimuli can be highly informative, and we suggest that the "IronChip" could also prove useful in the analysis of human patient samples. Recently, we increased the number of different relevant genes that are represented on the "IronChip" to nearly 300 (version 3.0) (data not shown). This should further enhance its utility in defining precise gene response patterns and hence to ultimately understand the networks that operate within human iron metabolism.
Moreover, we also established an analogous microarray platform with murine cDNAs (data not shown). The murine "IronChip" will not only facilitate cross-species comparisons, but in particular facilitate access to the growing pool of genetic murine (red) indicates a more than 3 fold decrease in mRNA levels.
(red) indicates a decrease in mRNA levels between at least 1.4 fold and 2.9 fold.
(green) indicates a more than 3 fold increase in mRNA levels. (green) indicates an increase in mRNA levels between at least 1.4 fold and 2.9 fold.
(grey) indicates no significant change in mRNA levels. 
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